BSE Live
Feb 11, 09:46Prev. Close
74.80
Open Price
74.05
Bid Price (Qty.)
75.00 (2)
Offer Price (Qty.)
75.54 (36)
NSE Live
Feb 11, 09:46Prev. Close
74.18
Open Price
74.00
Bid Price (Qty.)
74.73 (7)
Offer Price (Qty.)
74.97 (74)
| Key Financial Ratios of Alpa Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 1.95 | 1.27 | 2.26 | 2.85 | 3.68 | |
| Diluted EPS (Rs.) | 1.95 | 1.27 | 2.26 | 2.85 | 3.68 | |
| Cash EPS (Rs.) | 2.48 | 1.82 | 2.76 | 3.21 | 4.07 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 52.39 | 50.34 | 49.07 | 46.80 | 44.82 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 52.39 | 50.34 | 49.07 | 46.80 | 44.82 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 40.86 | 37.07 | 29.59 | 30.12 | 25.43 | |
| PBDIT/Share (Rs.) | 3.05 | 2.88 | 4.12 | 6.51 | 6.13 | |
| PBIT/Share (Rs.) | 2.51 | 2.36 | 3.62 | 6.15 | 5.74 | |
| PBT/Share (Rs.) | 2.41 | 2.09 | 3.11 | 4.33 | 5.05 | |
| Net Profit/Share (Rs.) | 1.94 | 1.30 | 2.26 | 2.85 | 3.68 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 7.46 | 7.78 | 13.92 | 21.61 | 24.12 | |
| PBIT Margin (%) | 6.13 | 6.37 | 12.23 | 20.41 | 22.57 | |
| PBT Margin (%) | 5.90 | 5.64 | 10.51 | 14.37 | 19.87 | |
| Net Profit Margin (%) | 4.74 | 3.50 | 7.65 | 9.45 | 14.46 | |
| Return on Networth / Equity (%) | 3.69 | 2.57 | 4.61 | 6.08 | 8.20 | |
| Return on Capital Employed (%) | 4.77 | 4.67 | 7.33 | 13.07 | 8.15 | |
| Return on Assets (%) | 3.10 | 2.12 | 3.76 | 4.64 | 5.33 | |
| Total Debt/Equity (X) | 0.00 | 0.01 | 0.06 | 0.11 | 0.26 | |
| Asset Turnover Ratio (%) | 65.52 | 60.64 | 49.18 | 49.10 | 36.88 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 4.54 | 4.17 | 4.22 | 3.57 | 2.31 | |
| Quick Ratio (X) | 3.93 | 3.54 | 3.62 | 3.14 | 2.01 | |
| Inventory Turnover Ratio (X) | 6.85 | 5.56 | 4.54 | 4.86 | 3.57 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 23.94 | 56.34 | 66.35 | 60.10 | 69.84 | |
| EV/Net Operating Revenue (X) | 0.28 | 0.72 | 1.07 | 0.95 | 1.31 | |
| EV/EBITDA (X) | 3.73 | 9.28 | 7.65 | 4.39 | 5.41 | |
| MarketCap/Net Operating Revenue (X) | 0.35 | 0.71 | 1.31 | 1.34 | 1.50 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.27 | 0.53 | 0.79 | 0.86 | 0.85 | |
| Price/Net Operating Revenue | 0.35 | 0.71 | 1.31 | 1.34 | 1.50 | |
| Earnings Yield | 0.14 | 0.05 | 0.06 | 0.07 | 0.10 |
04.12.2025
Alpa Labs Consolidated September 2025 Net Sales at Rs 26.26 crore, up 5.29% Y-o-Y
27.11.2025
Alpa Labs Standalone September 2025 Net Sales at Rs 25.63 crore, up 2.78% Y-o-Y
12.06.2025
Alpa Labs Standalone March 2025 Net Sales at Rs 39.11 crore, up 65.68% Y-o-Y
05.06.2025
Alpa Labs Consolidated March 2025 Net Sales at Rs 39.92 crore, up 69.1% Y-o-Y
04.12.2025
Alpa Labs Consolidated September 2025 Net Sales at Rs 26.26 crore, up 5.29% Y-o-Y
27.11.2025
Alpa Labs Standalone September 2025 Net Sales at Rs 25.63 crore, up 2.78% Y-o-Y
12.06.2025
Alpa Labs Standalone March 2025 Net Sales at Rs 39.11 crore, up 65.68% Y-o-Y
05.06.2025
Alpa Labs Consolidated March 2025 Net Sales at Rs 39.92 crore, up 69.1% Y-o-Y